_________ is a drug developed specifically for the treatment of smoking and works by competing with nicotine in binding to nicotine receptors in the brain.
a. Varenicline
b. Bupropion
c. Fluoxetine
d. Nicorette
Question 2
Research on the use of nicotine replacement therapies leads to the conclusion that _________.
a. there are no demonstrable differences in effectiveness between different nicotine replacement therapies
b. they are only slightly more effective than placebos
c. there may be significant long-term consequences to their use
d. pairing them with behavioral therapies does little to enhance treatment effectiveness
Patients with Parkinson's disease embroyonic stem cell treatment
Damage to the Insula and Smoking Cessation
The digital image of a fetus shows a well-developed head and a comparatively smaller body. At 7 ...
How the Wernicke-Geschwind model works in a person who is responding to a heard question and reading ...
Per capita consumption of power is high in the developed world and highest in the United States
Drug Naming